Buy Used
$4.00
FREE Shipping on orders over $35.
Condition: Used: Very Good
Comment: Eligible for Amazon's FREE Super Saver/Prime Shipping, 24/7 Customer Service, and package tracking. 100% Satisfaction Guarantee.
Add to Cart
Have one to sell? Sell on Amazon
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See this image

Free To Choose Medicine: How Faster Access to New Drugs Would Save Countless Lives and End Needless Suffering Paperback – July 1, 2010


Amazon Price New from Used from
Paperback
"Please retry"
$2.84 $0.01

Customers Who Viewed This Item Also Viewed

NO_CONTENT_IN_FEATURE
NO_CONTENT_IN_FEATURE

Product Details

  • Paperback: 88 pages
  • Publisher: The Heartland Institute (July 1, 2010)
  • Language: English
  • ISBN-10: 1934791326
  • ISBN-13: 978-1934791325
  • Product Dimensions: 8.9 x 5.8 x 0.3 inches
  • Shipping Weight: 4 ounces
  • Average Customer Review: 4.8 out of 5 stars  See all reviews (8 customer reviews)
  • Amazon Best Sellers Rank: #2,793,021 in Books (See Top 100 in Books)

Editorial Reviews

Review

Bart Madden brings to his task a thorough knowledge of the issues that must be confronted and a deep concern for improving the rules that govern FDA processes. It s about defining an FDA track that empowers the patients and physicians who have the relevant knowledge and need the freedom to choose to use that knowledge without harming others. This is a book that can be studied fruitfully by all who have a concern for these problems. It is fundamentally bipartisan and should be read in that spirit. --Vernon L. Smith, Economic Science Institute, Chapman University, Nobel Laureate in Economics, 2002

Free To Choose Medicine is full of disturbing data about the unintended consequences of our nation s quest for safe drugs seemingly without regard to cost. Bart Madden explains how we have lost sight of the goals of encouraging innovation, speed to market, and quick access for suffering patients, and he lays out a realistic plan for getting back on track. --Hon. Jim DeMint, U.S. Senator - South Carolina

Bart Madden shines a bright light on the all-too-invisible damage caused by the FDA s self-protective, dysfunctional, and ultimately lethal drug approval process. He explains how the FDA bureaucracy protects itself while allowing millions of people to suffer and die who could be helped by faster access to the newest medicines. The FDA uses approval processes appropriate to an era of adding machines and not super computers. Madden offers a 21st century information-age solution in Free To Choose Medicine that would give consumers control over health decisions, allow faster access to life-saving and life-enhancing drugs, and ultimately reduce the cost of new medicines. This concise book explains how to keep the FDA monopoly from stifling innovation and crippling the life sciences industry. Madden offers the right cure for the ailing FDA. --Grace-Marie Turner, President, Galen Institute

Free To Choose Medicine is full of disturbing data about the unintended consequences of our nation s quest for safe drugs seemingly without regard to cost. Bart Madden explains how we have lost sight of the goals of encouraging innovation, speed to market, and quick access for suffering patients, and he lays out a realistic plan for getting back on track. --Hon. Jim DeMint, U.S. Senator - South Carolina

Bart Madden shines a bright light on the all-too-invisible damage caused by the FDA s self-protective, dysfunctional, and ultimately lethal drug approval process. He explains how the FDA bureaucracy protects itself while allowing millions of people to suffer and die who could be helped by faster access to the newest medicines. The FDA uses approval processes appropriate to an era of adding machines and not super computers. Madden offers a 21st century information-age solution in Free To Choose Medicine that would give consumers control over health decisions, allow faster access to life-saving and life-enhancing drugs, and ultimately reduce the cost of new medicines. This concise book explains how to keep the FDA monopoly from stifling innovation and crippling the life sciences industry. Madden offers the right cure for the ailing FDA. --Grace-Marie Turner, President, Galen Institute

About the Author

Bartley J. Madden is an independent researcher whose current focus is on market-based solutions to public policy issues. His writing about the proposed Dual Track system to circumvent the FDA s monopoly on access to not-yet-approved drugs has appeared in Regulation, Cancer Biotherapy & Radiopharmaceuticals, and Medical Hypotheses, as well as a monograph titled More Choices, Better Health published by The Heartland Institute.

After receiving a BS in mechanical engineering, working as an engineer, and spending time in the Army, Madden earned an MBA at the University of California - Berkeley. In 1969 he co-founded Callard, Madden & Associates, where his research was instrumental in developing what is known as the CFROI (cash-flow-return-on-investment) valuation model, which is widely used by large money management firms today.

After managing portfolios for Harbor Capital Advisors for eight years, Madden joined HOLT Value Associates in the early 1990s, a firm created to extend the CFROI framework and provide consulting services to portfolio managers and corporate managers. HOLT was acquired by Credit Suisse in 2002, at which time Madden became a Managing Director of Credit Suisse/HOLT. He retired from Credit Suisse in late 2003.


More About the Authors

Discover books, learn about writers, read author blogs, and more.

Customer Reviews

4.8 out of 5 stars
5 star
7
4 star
0
3 star
1
2 star
0
1 star
0
See all 8 customer reviews
This book is refreshing in its creativity and use of logic.
Sloane Frost
Also a Nobel Laureate, a U.S. Senator, and several health care non-profit foundations.
Marie
This is one of the more important books on the topic of FDA reform.
Bruno Behrend

Most Helpful Customer Reviews

33 of 33 people found the following review helpful By Marie on August 7, 2010
Format: Paperback
There was a time when doctors and patients got to decide. Now--not. Now, it's the FDA and their "one rule fits everyone." Which turns out doesn't work so well. Especially for patients who cannot wait ten years for some new drug to be approved by them. After describing the reality of this, author Madden brings to the issue of improving health care his experience from the business world. He makes us aware that getting drugs to patients via the FDA, or any other way, is actually a system; and he applies the systems mindset to our health care dilemma. Then he forewarns us of how the FDA has typically responded to any perceived threat to their monopolistic power. Then he proposes a simple, yet powerful plan that lets us be able to decide for ourselves which, to repeat, we now cannot do. That is, the option to put decision-making back where it belongs--in the hands of doctors and their patients. Madden reveals how the seed of that idea is already somewhat at work and is successful. After presenting his sound plan, he concludes with a detailed call for grass roots participation and asks that the public and health care professionals raise a demand for government to enact law on the public's behalf. Even a former director at the FDA likes Madden's proposal. Also a Nobel Laureate, a U.S. Senator, and several health care non-profit foundations. If enacted, a Free To Choose Medicine Act would, over time, fundamentally restructure both the pharmaceutical industry and the FDA, updating them to match contemporary needs and the speed of medical innovations, and thus bring life-improving and life-saving benefits to millions of people worldwide. So, either don't ever get sick, or read this short, concise book that shows how a Free To Choose MedicineAct could save your life or that of a family member.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
7 of 7 people found the following review helpful By Bruno Behrend on August 5, 2010
Format: Paperback
This is one of the more important books on the topic of FDA reform. It highlights the need for an improved drug approval program that gives Americans access to better drugs, faster, and at a lower cost.

This book explains why it takes so long to bring new drugs to market, and offers intelligent and doable alternatives to the existing system.

Key insights of this book are that;

* The FDA is the bottleneck in the drug delivery system, unnecessarily slowing down the process of drug approval.

* This bottleneck is causing the unneeded pain, suffering, and even premature death of citizens who deserve to be able to get access to drug that may help them.

* That FDA can test for safety without testing for "efficacy."

* That allowing citizens, under the care of their physician, access drugs that have completed the FDA's first round of trials, will create a faster approval process and better testing regime.

* There is a superior system for tracking reactions and effects of a new drug than the current and cumbersome FDA trial process.

This book matters to YOU! You may someday be in need of a drug that has been developed specifically to address some future ailment. You may be denied access to that drug, despite your willingness to try it knowing of all potential risks. There are better ways to approve drugs than the current system, and 'Free to Choose Medicine explains why, and offers an excellent alternative system.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
6 of 6 people found the following review helpful By jo on August 7, 2010
Format: Paperback
The basic concept that Madden presents should resonate with all who read it -- that people should have the right (i.e. the freedom) to decide for themselves when facing alternative health care options. Roadblocks to new ideas typically come from entrenchedspecial interests, such as the FDA, that seek to protect their turf regardless of how well they serve the public's needs. Recognizing these challenges, Madden presents an alternative that leaves all the existing options intact, but at the same time allows the development of new alternatives -- and choices.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again
4 of 4 people found the following review helpful By Sloane Frost on August 22, 2010
Format: Paperback
Mr. Madden's book is an excellent look into what life would be like without such a Draconian pharmaceutical review process. Dual Tracking is an innovative step towards a competitive market for life-saving treatments as well as a critical way for patients to regain control of their own lives. His ideas are clearly presented, well cited, thoroughly analyzed, and force the reader to reconsider what has become one of government's most dogmatic (and perhaps overrated) roles. This book is refreshing in its creativity and use of logic. Free to Choose Medicine should be required reading for every American - health policy students, FDA personnel, and John Q. Public alike.
Comment Was this review helpful to you? Yes No Sending feedback...
Thank you for your feedback. If this review is inappropriate, please let us know.
Sorry, we failed to record your vote. Please try again

Customer Images

Search